Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries - PubMed (original) (raw)

Clinical Trial

Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries

P P van Geel et al. Hypertension. 2000 Mar.

Abstract

An adenine/cytosine (A/C) base substitution at position 1166 in the angiotensin II type 1 receptor (AT(1)R) gene is associated with the incidence of essential hypertension and increased coronary artery vasoconstriction. However, it is still unknown whether this polymorphism is associated with a difference in angiotensin II responsiveness. Therefore, we assessed whether the AT(1)R polymorphism is associated with different responses to angiotensin II in isolated human arteries. Furthermore, we evaluated whether inhibition of the renin-angiotensin system modifies the effect of the AT(1)R polymorphism. One hundred twelve patients who were undergoing coronary artery bypass graft surgery were prospectively randomized to receive an ACE inhibitor or a placebo for 1 week before surgery. Excess segments of the internal mammary artery were exposed to angiotensin II (0.1 nmol/L to 1 micromol/L) and KCl (60 mmol/L) in organ bath experiments. Patients homozygous for the C allele (n=17) had significantly greater angiotensin II responses (percentage of this maximal KCl-induced response) than did patients genotyped with AA+AC (n=95, P<0.05). Although ACE inhibition increased the response to angiotensin II, the difference in the response to angiotensin II, between CC and AA+AC patients remained intact in ACE inhibitor-treated patients. These results indicate increased responses to angiotensin II in patients with the CC genotype. The mechanism is preserved during ACE inhibition, which in itself also increased the response to angiotensin II. This reveals that the A1166C polymorphism may be in linkage disequilibrium with a functional mutation that alters angiotensin II responsiveness, which may explain the described relation between this polymorphism and cardiovascular abnormalities.

PubMed Disclaimer

Cited by

Genetic determinants of vascular reactivity.
Henrion D, Benessiano J, Iglarz M, Philip I, Levy BI. Henrion D, et al. Curr Hypertens Rep. 2002 Feb;4(1):41-8. doi: 10.1007/s11906-002-0052-z. Curr Hypertens Rep. 2002. PMID: 11790291 Review.
Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.
Tang Z, Tracy RP. Tang Z, et al. J Thromb Thrombolysis. 2001 Feb;11(1):49-81. doi: 10.1023/a:1008956327032. J Thromb Thrombolysis. 2001. PMID: 11248790 Review. No abstract available.
Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension.
Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF. Amberg GC, et al. J Clin Invest. 2003 Sep;112(5):717-24. doi: 10.1172/JCI18684. J Clin Invest. 2003. PMID: 12952920 Free PMC article.
Angiotensin II receptors and drug discovery in cardiovascular disease.
Dasgupta C, Zhang L. Dasgupta C, et al. Drug Discov Today. 2011 Jan;16(1-2):22-34. doi: 10.1016/j.drudis.2010.11.016. Epub 2010 Dec 13. Drug Discov Today. 2011. PMID: 21147255 Free PMC article. Review.
Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction.
Mishra A, Srivastava A, Kumar S, Mittal T, Garg N, Agarwal SK, Pande S, Mittal B. Mishra A, et al. Indian Heart J. 2015 May-Jun;67(3):214-21. doi: 10.1016/j.ihj.2015.04.013. Epub 2015 May 7. Indian Heart J. 2015. PMID: 26138177 Free PMC article.

Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries - PubMed (original) (raw)